Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00101088
Status:
TERMINATED
Last Update Posted:
2013-01-14
First Post:
2005-01-07
Brief Title:
Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Blastic Phase Chronic Myelogenous Leukemia |
| Chronic Myelogenous Leukemia BCR-ABL1 Positive |
| Chronic Phase Chronic Myelogenous Leukemia |
| Relapsing Chronic Myelogenous Leukemia |
| Accelerated Phase Chronic Myelogenous Leukemia |
Keywords: